Biomedical Engineering Reference
In-Depth Information
King SB, Smith SC, Hirshfeld JW, et al. 2007 Focused Update of the ACC/AHA/SCAI 2005
Guideline Update for Percutaneous Coronary Intervention. A Report of the American College
of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation
2007 Dec 13;DOI: 10.1161/CIRCULATIONAHA.107.188208.
Kipshidze N, Tsapenko M, Iversen P, Burger D. Antisense therapy for restenosis following percu-
taneous coronary intervention. Expert Opin Biol Ther 2005;5:79-89.
Kollum M, Farb A, Schreiber R, et al. Particle debris from a nanoporous stent coating obscures
potential antiproliferative effects of tacrolimus-eluting stents in a porcine model of restenosis.
Catheter Cardiovasc Interv 2005;64:85-90.
Kong D, Melo LG, Mangi AA, et al. Enhanced inhibition of neointimal hyperplasia by genetically
engineered endothelial progenitor cells. Circulation 2004;109:1769-75.
Koo BK, Kim YS, Park KW, et al. Effect of celecoxib on restenosis after coronary angioplasty
with a Taxus stent (COREA-TAXUS trial): an open-label randomised controlled study. Lancet
2007;370:567-74.
Laarman GJ, Suttorp MJ, Dirksen MT, et al. Paclitaxel-Eluting versus Uncoated Stents in Primary
Percutaneous Coronary Intervention. NEJM 2006; 355:1105-1113.
Lagerqvist B, James SK, Stenestrand U, et al. Long-Term Outcomes with Drug-Eluting Stents
versus Bare-Metal Stents in Sweden. NEJM 2007;356:1009-19.
Lee SH, Ko YG, Jang Y, Kwon HM, et al. Sirolimus- versus Paclitaxel-Eluting Stent Implantation
for Unprotected Left Main Coronary Artery Stenosis. Cardiology 2005;104:181-185.
Malenka DJ, Kaplan AV, Lucas FL, et al. Outcomes following coronary stenting in the era of
bare-metal vs the era of drug-eluting stents. JAMA 2008;299:2868-76.
Margolis J, McDonald J, Heuser R, et al. Systemic nanoparticle paclitaxel (nab-paclitaxel) for
in-stent restenosis I (SNAPIST-I): a first-in-human safety and dose-finding study. Clin Cardiol
2007;30:165-70.
Marroquin OC, Selzer F, Mulukutla S, et al. A Comparison of Bare-Metal and Drug-Eluting Stents
for Off-Label Indications. NEJM 2008;358:342-352.
Mauri L, Hsieh WH, Massaro JM, et al. Stent Thrombosis in Randomized Clinical Trials of Drug-
Eluting Stents. NEJM 2007;356:1020-9.
Mauri L, Silbaugh TS, Garg P, et al. Drug-eluting or bare-metal stents for acute myocardial infarc-
tion. N Engl J Med 2008;359:1330-42.
Mehilli J, Dibra A, Kastrati A, et al. Randomized trial of paclitaxel- and sirolimus-eluting stents
in small coronary vessels. Eur Heart J 2006;27:260-6.
Meng QH, Jamal W, Hart SL, McEwan JR. Application to Vascular Adventitia of a Nonviral
Vector for TIMP-1 Gene Therapy to Prevent Intimal Hyperplasia. Hum Gene Ther
2006;17:717-27.
Morice MC, Colombo A, Meier B, et al. Sirolimus- vs paclitaxel-eluting stents in de novo coro-
nary artery lesions: the REALITY trial: a randomized controlled trial. JAMA
2006;295:895-904.
Muni NI, Gross TP. Problems with drug-eluting coronary stents - the FDA perspective. N Engl
J Med 2004;351:1593-5.
Nakao A, Huang CS, Stolz DB, et al. Ex vivo carbon monoxide delivery inhibits intimal hyper-
plasia in arterialized vein grafts. Cardiovasc Res 2010 Oct 12 [Epub ahead of print].
Nebeker J, Virmani R, Bennett CL, et al. Hypersensitivity Cases Associated With Drug-Eluting
Coronary Stents. A Review of Available Cases From the Research on Adverse Drug Events and
Reports
(RADAR)
Project.
Journal
of
the
American
College
of
Cardiology
2006;47:175-181.
O'Dwyer J. Evidence-based medicine and drug-eluting stents. Med Device Technol 2004;
15: 34-7.
Onuma Y, Ormiston J, Serruys PW. Bioresorbable Scaffold Technologies. Circ J 2011;75:509-20.
Ortolani P, Ardissino D, Cavallini C, et al., for the SES-SMART Investigators. Effect of sirolimus-
eluting stent in diabetic patients with small coronary arteries (A SES-SMART Substudy).
Am J Cardiol 2005;96:1393-8.
Park DW, Park SW, Park KH, et al. Frequency of and risk factors for stent thrombosis after
drug-eluting stent implantation during long-term follow-up. Am J Cardiol 2006;98:352-6.
Search WWH ::
Custom Search